Acepodia Funding & Investors
Acepodia is using its proprietary bioconjugation technology to develop the next wave of off-the-shelf cell therapies for cancer.
acepodia.comTotal Amount Raised: $256,000,000
Acepodia Funding Rounds
Series D
$100,000,000
Series D Investors
Digital Mobile VentureSeries C
$109,000,000
Series C Investors
Digital Mobile VentureSeries B
$47,000,000
Series B Investors
Ridgeback CapitalCDIB Capital8VCDEFTA PartnersSeries D
$100,000,000
Series D Investors
Digital Mobile VentureSeries C
$109,000,000
Series C Investors
Digital Mobile VentureSeries B
$47,000,000
Series B Investors
Ridgeback CapitalCDIB Capital8VCDEFTA Partners
Funding info provided by Diffbot.